(Q28378985)

24 June 2017

The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats (English)

1 reference

24 June 2017

1 reference

Okuyama S

1

1 reference

24 June 2017

Chaki S

2

1 reference

24 June 2017

Kawashima N

3

1 reference

24 June 2017

Suzuki Y

4

1 reference

24 June 2017

Ogawa S

5

1 reference

24 June 2017

Kumagai T

6

1 reference

24 June 2017

Nakazato A

7

1 reference

24 June 2017

Nagamine M

8

1 reference

24 June 2017

Yamaguchi K

9

1 reference

24 June 2017

Tomisawa K

10

1 reference

24 June 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

British Journal of Pharmacology

24 June 2017

1 reference

24 June 2017

121

1 reference

24 June 2017

3

1 reference

24 June 2017

515-525

1 reference

In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors

24 June 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

Limbic System Abnormalities Identified in Schizophrenia Using Positron Emission Tomography With Fluorodeoxyglucose and Neocortical Alterations With Deficit Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

Serotonin 5-HT2 receptor, dopamine D2 receptor, and alpha 1 adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Dopamine and the Pathophysiology of Dyskinesias Induced by Antipsychotic Drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Treatment of positive and negative symptoms: pharmacologic approaches

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Design and synthesis of 2-naphthoate esters as selective dopamine D4 antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Clozapine: neuroleptic-induced EPS and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Startle response models of sensorimotor gating and habituation deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Alternative splicing directs the expression of two D2 dopamine receptor isoforms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Seroquel: electrophysiological profile of a potential atypical antipsychotic.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

The effects of radio-frequency lesions of the nucleus accumbens on d-amphetamine-induced locomotor and rearing behavior in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Modulation of the clozapine structure increases its selectivity for the dopamine D4 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

A rat model of phencyclidine psychosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Effect of NE-100, a novel sigma receptor ligand, on phencyclidine- induced delayed cognitive dysfunction in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Developments in the drug treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole: a potent, selective antagonist at human cloned dopamine D4 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

The role of 5-HT2A receptors in antipsychotic activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Dopamine receptor pharmacology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

(S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Pharmacokinetic study of apomorphine-induced stereotypy in food deprived rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Schizophrenia and the frontal lobe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701164

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0701164

1 reference

24 June 2017

0 references

1 reference